1 – 10 of 10
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
- Assessing the Nationwide Impact of a Registry-Based Randomized Clinical Trial on Cardiovascular Practice
-
Combined association of key risk factors on ischaemic outcomes and bleeding in patients with myocardial infarction
Lindholm, Daniel ; Sarno, Giovanna ; Erlinge, David LU
;
Svennblad, Bodil
;
Hasvold, Lars Pål
;
Janzon, Magnus
;
Jernberg, Tomas
and
James, Stefan K.
(2019)
In Heart
105(15).
p.1175-1181
Mark
-
Clinical and angiographic outcomes of bioabsorbable vs. permanent polymer drug-eluting stents in Sweden : a report from the Swedish Coronary and Angioplasty Registry (SCAAR)
Buccheri, Sergio ; James, Stefan ; Lindholm, Daniel ; Fröbert, Ole ; Olivecrona, Göran K. LU ; Persson, Jonas LU ; Hambraeus, Kristina ; Witt, Nils ; Erlinge, David LU
and
Angerås, Oskar
, et al.
(2019)
In European Heart Journal
40(31).
p.2607-2615
Mark
- 2018
- Stent thrombosis rates the first year and beyond with new- and old-generation drug-eluting stents compared to bare metal stents
-
Bioabsorbable polymer everolimus-eluting stents in patients with acute myocardial infarction : A report from the Swedish Coronary Angiography and Angioplasty Registry
Buccheri, Sergio ; Sarno, Giovanna ; Lagerqvist, Bo ; Olivecrona, Göran LU ; Hambraeus, Kristina ; Witt, Nils ; Lindholm, Daniel ; Erlinge, David LU
;
Angerås, Oskar
and
James, Stefan
(2018)
In EuroIntervention
14(5).
p.562-569
Mark
- 2017
- Real-life clinical outcomes with everolimus eluting platinum chromium stent with an abluminal biodegradable polymer in patients from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)
- 2016
- Impact of thrombus aspiration during ST-Elevation Myocardial Infarction : a six month composite endpoint and risk of stroke analyses of the TASTE trial
- 2014
- Stent Thrombosis in New-Generation Drug-Eluting Stents in Patients With STEMI Undergoing Primary PCI: A Report From SCAAR.
- 2013
- Initial clinical experience with an everolimus eluting platinum chromium stent (Promus Element) in unselected patients from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)
- 2012
- Lower risk of stent thrombosis and restenosis with unrestricted use of onew-generation' drug-eluting stents: a report from the nationwide Swedish Coronary Angiography and Angioplasty Registry (SCAAR)